General Information of Drug (ID: DM39QWN)

Drug Name
ANS-6637 Drug Info
Indication
Disease Entry ICD 11 Status REF
Substance use disorder 6C4Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM39QWN

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ALD-401 DM2U530 Cerebrovascular ischaemia 8B1Z Phase 2 [2]
GS-6637 DMXG3T1 Substance use disorder 6C4Z Phase 1 [3]
FP-045 DMV9FTH Cardiovascular disease BA00-BE2Z Phase 1 [4]
Daidzin DMFCMPS N. A. N. A. Terminated [5]
Nicotinamide-Adenine-Dinucleotide DM9LRKB N. A. N. A. Investigative [5]
crotylaldehyde DMTWRQI Discovery agent N.A. Investigative [5]
ISOFORMONENTIN DM5CMA8 Discovery agent N.A. Investigative [6]
prunetin DMPD41Q Discovery agent N.A. Investigative [6]
CVT-10216 DMDH6PJ Alcohol dependence 6C40.2 Investigative [7]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mitochondrial aldehyde dehydrogenase (ALDH2) TTFLN4T ALDH2_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. Clin Cancer Res. 2011 Dec 1;17(23):7265-72.
3 Clinical pipeline report, company report or official report of Gilead.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
6 Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. J Med Chem. 2008 Aug 14;51(15):4482-7.
7 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2595).